SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-18-003091
Filing Date
2018-03-16
Accepted
2018-03-16 17:06:33
Documents
67
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2017_actiniumpharma.htm 10-K 1386838
2 SIXTH AMENDMENT TO THE 2013 AMENDED AND RESTATED STOCK PLAN, AS AMENDED f10k2017ex10-56_actinium.htm EX-10.56 6049
3 OFFER LETTER, EFFECTIVE JANUARY 2, 2018, BETWEEN DALE L. LUDWIG AND ACTINIUM PHA f10k2017ex10-57_actinium.htm EX-10.57 25225
4 INDEMNIFICATION AGREEMENT, DATED JANUARY 5, 2018, BETWEEN DALE L. LUDWIG AND ACT f10k2017ex10-58_actinium.htm EX-10.58 72591
5 OFFER LETTER, EFFECTIVE JANUARY 31, 2018, BETWEEN ANIL KAPUR AND ACTINIUM PHARMA f10k2017ex10-59_actinium.htm EX-10.59 25654
6 INDEMNIFICATION AGREEMENT, DATED FEBRUARY 8, 2018, BETWEEN ANIL KAPUR AND ACTINI f10k2017ex10-60_actinium.htm EX-10.60 77473
7 CONSENT OF GBH CPAS, PC f10k2017ex23-1_actinium.htm EX-23.1 1988
8 CERTIFICATION f10k2017ex31-1_actinium.htm EX-31.1 10459
9 CERTIFICATION f10k2017ex31-2_actinium.htm EX-31.2 10300
10 CERTIFICATION f10k2017ex32-1_actinium.htm EX-32.1 3202
11 CERTIFICATION f10k2017ex32-2_actinium.htm EX-32.2 3274
12 GRAPHIC image_003.jpg GRAPHIC 148755
13 GRAPHIC image_001.jpg GRAPHIC 18556
  Complete submission text file 0001213900-18-003091.txt   5064475

Data Files

Seq Description Document Type Size
14 XBRL INSTANCE FILE atnm-20171231.xml EX-101.INS 692492
15 XBRL SCHEMA FILE atnm-20171231.xsd EX-101.SCH 43677
16 XBRL CALCULATION FILE atnm-20171231_cal.xml EX-101.CAL 42639
17 XBRL DEFINITION FILE atnm-20171231_def.xml EX-101.DEF 186518
18 XBRL LABEL FILE atnm-20171231_lab.xml EX-101.LAB 332385
19 XBRL PRESENTATION FILE atnm-20171231_pre.xml EX-101.PRE 274811
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36374 | Film No.: 18696529
SIC: 2834 Pharmaceutical Preparations